Calcium is the most abundant mineral in the human body, serving as the primary structural component of the skeletal system and teeth while acting as a vital second messenger for neuromuscular, cardiovascular, and endocrine functions. Approximately 99% of body calcium is sequestered in bone tissue, providing mechanical strength and acting as a metabolic reservoir to maintain tightly regulated serum ionized calcium levels. High-level evidence indicates that while calcium is essential for maintaining bone mineral density (BMD) and preventing osteoporotic fractures, isolated supplementation without critical co-factors carries potential clinical risks, including vascular calcification and nephrolithiasis.
| Type | Mineral |
| Active Cmpd | Elemental Calcium (Ca²⁺) |
| Source | Dairy, Leafy Greens, Fortified Foods |
| Dose Range | 500–1,200 mg/day (total intake) |
| Half-life | Homeostatically regulated |
| Main Benefit | Bone mineralization and BMD maintenance |
| Absorption | Variable (~20–40%) |
Calcium is widely used for bone health and the prevention of fractures in older adults, often paired with Vitamin D. However, recent evidence synthesis highlights the importance of obtaining calcium primarily through diet, using supplements only to fill dietary gaps, due to concerns regarding cardiovascular disease and kidney stone risks with high-dose supplementation.
Aliases
Key points (high-level summary)
What people use it for
Calcium is a group 2 alkaline earth metal and an essential macromineral required for every physiological process in the human body. Because the body cannot synthesize calcium, it must be acquired through dietary sources or supplementation. Serum calcium levels are maintained within a extremely narrow range (8.5–10.2 mg/dL) through a complex homeostatic feedback loop involving the parathyroid glands, kidneys, and bones.
For Skeletal Health and Fractures:
For Gestational Hypertension:
| Outcome / Goal | Effect* | Consistency** | Evidence quality | Trials*** | Notes (population, duration, dose) |
|---|---|---|---|---|---|
| Bone Mineral Density (BMD) | High | High | 20+ RCTs | [Increases BMD slightly when combined with Vitamin D][1][2] | |
| Gestational Hypertension & Preeclampsia | High | High | 15+ RCTs | [Reduces risk in pregnant women with low baseline dietary calcium][3][4] | |
| Skeletal Fracture Risk | Moderate | High | 20+ RCTs | [Mixed evidence; some trials show modest reduction, others no significant effect][5][6][2:1][7][8] | |
| Cardiovascular Disease Risk | Moderate | Moderate | Meta-analyses | [Mixed evidence; some meta-analyses suggest increased risk, while others show no association][9][10][11] | |
| Kidney Stone Formation | High | High | 10+ RCTs | [Small increased risk of nephrolithiasis in susceptible individuals][7:1][12][13] |
*Effect: Direction and magnitude. **Consistency: Agreement across studies. ***Trials: Number of supporting studies.
The primary clinical application of calcium supplementation is the prevention of osteoporosis and fractures. Meta-analyses consistently show that calcium, particularly when co-administered with Vitamin D, reduces bone turnover markers and slows the age-related decline in bone mineral density. The fracture risk reduction is most pronounced in institutionalized elderly patients and those with documented dietary deficiencies.
The cardiovascular impact of calcium supplementation is a subject of ongoing debate. While dietary calcium is considered cardioprotective, rapid spikes in serum calcium following bolus supplementation may contribute to vascular calcification and stiffening of the arteries. Some large meta-analyses suggest a modest increase in the risk of myocardial infarction associated with isolated calcium supplements, prompting guidelines to recommend dietary sources over pills when possible.
While high dietary calcium intake paradoxically lowers the risk of kidney stones by binding oxalates in the gut, supplemental calcium taken between meals can increase urinary calcium excretion (hypercalciuria), slightly elevating the risk of nephrolithiasis (kidney stones).
Standard dosing in studies
Forms and bioavailability
Special populations
Common side effects
Less common but serious side effects
Pharmacokinetic interactions (how drugs are processed)
Pharmacodynamic interactions (additive / opposing effects)
Changes in bone mineral density are typically measured after 1 to 2 years of continuous supplementation, though biochemical markers of bone turnover decline within weeks.
Calcium citrate is more easily absorbed, especially in older adults with low stomach acid or those on proton pump inhibitors. Calcium carbonate is more concentrated but must be taken with food.
Yes, but the goal should be to meet the RDA (1,000-1,200 mg) primarily through diet, using supplements only to make up the shortfall. Long-term high-dose supplementation carries risks.
Yes. Vitamin D is essential for the active transport of calcium across the intestinal lining. Without adequate Vitamin D, calcium absorption is severely limited.
Some meta-analyses suggest isolated calcium supplements may slightly increase cardiovascular risk by promoting arterial calcification, but this risk is minimized if calcium is obtained from food or kept within the recommended total daily limit.
Cong B, Zhang H. (2025). The effects of combined calcium and vitamin D supplementation on bone mineral density and fracture risk in postmenopausal women with osteoporosis: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskeletal Disorders. https://pubmed.ncbi.nlm.nih.gov/41063100/ ↩︎
Tang BM, et al. (2007). Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. The Lancet. https://pubmed.ncbi.nlm.nih.gov/17720017/ ↩︎ ↩︎
Hofmeyr GJ, et al. (2018). Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews. https://pubmed.ncbi.nlm.nih.gov/30277579/ ↩︎
Chen WY, et al. (2023). Clinical efficacy of low-dose aspirin combined with calcium in preventing preeclampsia: A systematic review and meta-analysis. Medicine. https://pubmed.ncbi.nlm.nih.gov/37653760/ ↩︎
Weaver CM, et al. (2016). Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporosis International. https://pubmed.ncbi.nlm.nih.gov/26510847/ ↩︎
Zhao JG, et al. (2017). Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. JAMA. https://pubmed.ncbi.nlm.nih.gov/29279934/ ↩︎
Jackson RD, et al. (2006). Calcium plus vitamin D supplementation and the risk of fractures. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/16481635/ ↩︎ ↩︎
Massé O, et al. (2026). Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis. BMJ. https://pubmed.ncbi.nlm.nih.gov/42161415/ ↩︎
Yang C, et al. (2020). The Evidence and Controversy Between Dietary Calcium Intake and Calcium Supplementation and the Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Cohort Studies and Randomized Controlled Trials. Journal of the American College of Nutrition. https://pubmed.ncbi.nlm.nih.gov/31625814/ ↩︎
Chung M, et al. (2016). Calcium Intake and Cardiovascular Disease Risk: An Updated Systematic Review and Meta-analysis. Annals of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/27776363/ ↩︎
Sim MG, et al. (2023). Association Between Calcium Supplementation and the Risk of Cardiovascular Disease and Stroke: A Systematic Review and Meta-Analysis. Heart, Lung and Circulation. https://pubmed.ncbi.nlm.nih.gov/37743221/ ↩︎
Bargagli M, et al. (2021). Calcium and Vitamin D Supplementation and Their Association with Kidney Stone Disease: A Narrative Review. Nutrients. https://pubmed.ncbi.nlm.nih.gov/34959915/ ↩︎
Shi L, et al. (2025). Association between calcium and vitamin D supplementation and increased risk of kidney stone formation in patients with osteoporosis in Southwest China: a cross-sectional study. BMJ open. https://pubmed.ncbi.nlm.nih.gov/39956606/ ↩︎